Controlled attenuation parameter for evaluating liver steatosis in type 2 diabetes patients

被引：0
|
作者：
Sporea, Ioan [1 ]
Mare, Ruxandra [1 ]
Lupusoru, Raluca [1 ]
Silviu, Nistorescu [1 ]
Popescu, Alina [1 ]
Sirli, Roxana [1 ]
Danila, Mirela [1 ]
机构：
[1] Victor Babes Univ Med & Pharm, Gastroenterol & Hepatol, Timisoara, Romania
来源：
JOURNAL OF HEPATOLOGY | 2019年 / 70卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
SAT-328
引用
收藏
页码：E784 / E784
页数：1
相关论文
共 50 条
  • [31] Noninvasive assessment of liver steatosis in children: the clinical value of controlled attenuation parameter
    Ferraioli, Giovanna
    Calcaterra, Valeria
    Lissandrin, Raffaella
    Guazzotti, Marinella
    Maiocchi, Laura
    Tinelli, Carmine
    De Silvestri, Annalisa
    Regalbuto, Corrado
    Pelizzo, Gloria
    Larizza, Daniela
    Filice, Carlo
    BMC GASTROENTEROLOGY, 2017, 17
  • [32] Controlled attenuation parameter reflects steatosis in compensated advanced chronic liver disease
    Piccinni, Rosangela
    Rodrigues, Susana G.
    Montani, Matteo
    Murgia, Giuseppe
    Delgado, Maria G.
    Casu, Stefania
    Stirnimann, Guido
    Semmo, Nasser
    De Gottardi, Andrea
    Dufour, Jean-Francois
    Berzigotti, Annalisa
    LIVER INTERNATIONAL, 2020, 40 (05) : 1151 - 1158
  • [33] Quantitative assessment of liver steatosis using ultrasound controlled attenuation parameter (Echosens)
    Ferraioli, Giovanna
    JOURNAL OF MEDICAL ULTRASONICS, 2021, 48 (04) : 489 - 495
  • [34] Controlled attenuation parameter in the diagnosis of different liver steatosis groups in children with obesity
    Yang, Lin
    Lin, Yan
    Zhu, Ya Fei
    Zhu, Yin Yan
    Liang, Zhen Ming
    Wu, Guang Sheng
    PEDIATRIC OBESITY, 2022, 17 (06):
  • [35] Controlled attenuation parameter for the assessment of fatty liver in patients with type 1 diabetes mellitus: which cutoffs to choose?
    Grzelka-Wozniak, Agata
    Uruska, Aleksandra
    Szymanska-Garbacz, Elektra
    Araszkiewicz, Aleksandra
    Jablkowski, Maciej
    Czupryniak, Leszek
    Zozulinska-Ziolkiewicz, Dorota
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2024, 134 (01):
  • [36] Quantitative assessment of liver steatosis using ultrasound controlled attenuation parameter (Echosens)
    Giovanna Ferraioli
    Journal of Medical Ultrasonics, 2021, 48 : 489 - 495
  • [37] Predicting Hepatic Steatosis in Living Liver Donors Via Controlled Attenuation Parameter
    Yen, Y. H.
    Kuo, F. Y.
    Lin, C. C.
    Chen, C. L.
    Chang, K. C.
    Tsai, M. C.
    Hu, T. H.
    TRANSPLANTATION PROCEEDINGS, 2018, 50 (10) : 3533 - 3538
  • [38] Validating controlled attenuation parameter in the assessment of hepatic steatosis in living liver donors
    Broering, Dieter
    Shawkat, Mohamed
    Albenmousa, Ali
    Abaalkhail, Faisal
    Alabbad, Saleh
    Al-Hamoudi, Waleed
    Alghamdi, Saad
    Alqahthani, Saleh
    Jaafari, Ahmad
    Troisi, Roberto
    Bzeizi, Khalid
    PLOS ONE, 2021, 16 (05):
  • [39] The Role of Controlled Attenuation Parameter (CAP) in Defining Significant Hepatic Steatosis in Chronic Liver Disease Patients
    Andrade, Patricia
    Rodrigues-Pinto, Eduardo
    Gaspar, Rui
    Lopes, Joanne
    Lopes, Susana
    Macedo, Guilherme
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S880 - S880
  • [40] Ultrasound and FibroScan® Controlled Attenuation Parameter in patients with MAFLD: head to head comparison in assessing liver steatosis
    Salmi, Andrea
    di Filippo, Luigi
    Ferrari, Clarissa
    Frara, Stefano
    Giustina, Andrea
    ENDOCRINE, 2022, 78 (02) : 262 - 269
12345